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Abstract
Purpose To report feasibility and potential benefits of
high-frequency jet ventilation (HFJV) in tumor ablations
techniques in liver, kidney, and lung lesions.
Methods This prospective study included 51 patients (14
women, mean age 66 years) bearing 66 tumors (56 hepatic,
5 pulmonary, 5 renal tumors) with a median size of
16 ± 8.7 mm, referred for tumor ablation in an intention-
to-treat fashion before preoperative anesthesiology visit.
Cancellation and complications of HFJV were prospec-
tively recorded. Anesthesia and procedure duration, as well
as mean CO2 capnea, were recorded. When computed
tomography guidance was used, 3D spacial coordinates of
an anatomical target \2 mm in diameter on 8 slabs of 4
slices of 3.75-mm slice thickness were registered.
Results HFJV was used in 41 of 51 patients. Of the ten
patients who were not candidate for HFJV, two patients
had contraindication to HFJV (severe COPD), three had
lesions invisible under HFJV requiring deep inspiration
apnea for tumor targeting, and five patients could not have
HFJV because of unavailability of a trained anesthetic
team. No specific complication or hypercapnia related to
HFJV were observed despite a mean anesthetic duration of
2 h and ventilation performed in procubitus (n = 4) or
lateral decubitus (n = 6). Measured internal target
movement was 0.3 mm in x- and y-axis and below the slice
thickness of 3.75 mm in the z-axis in 11 patients.
Conclusions HFJV is feasible in 80 % of patients
allowing for near immobility of internal organs during
liver, kidney, and lung tumor ablation.
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Percutaneous thermal ablative techniques, such as radio-
frequency ablation (RFA), microwave ablation (MWA), or
cryoablation, have become valuable alternatives to surgery
in selected patients with liver, kidney, or lung malignancies
[1–4]. During the procedure, one or several thermal probes
are placed in the target lesion under computed tomography
(CT) or ultrasound (US) guidance and thermal energy is
deposited in the tissue to achieve tissue destruction. The
success of this treatment modality is directly related to the
ability to induce both destruction of the tumor and of a
circumferential rim of normal parenchyma around the
tumor [5]. Taking into consideration that most devices are
able to create a single ablation of *4 cm in diameter [6]
and that, for instance, RFA or MWA is proposed for liver
lesions up to 3 cm in diameter, a precise positioning of
probes in the center of the lesion is critical. Quality and
reliability of the imaging guidance as well as operator’s
experience is therefore capital. Another parameter that
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needs to be taken into account is the mobility of the organs
during needle placement. Until recently, there was no other
way to obtain immobility of targeted lesions located in the
liver, kidney, or lung than apnea for patients under general
anesthesia.
High-frequency jet ventilation (HFJV) is a mechanical
ventilation method where high-flow, short-duration pulses
of pressurized gaz are delivered in the trachea through a
small caliber catheter [7]. Gas exchange is assured by high-
velocity gas flow washing the alveoli [8]. Initially, HFJV
has been developed for specific indications, such as surgery
of the larynx and trachea, because direct placement of this
HFJV catheter can be done though a minitracheostomy
leaving the larynx and trachea fully accessible for surgery.
Because HFJV is made of short and small pulses of air, it
induces very small amplitude respiratory movements. This
might be of significant interest for percutaneous ablation
procedures as recently demonstrated for other technics,
such as extracorporeal shockwave lithotripsy for kidney
stones [9, 10] and lung tumor radiotherapy [11]. However,
HFJV has its own limitations and carries a higher risk of
barotraumatic pneumothorax; its use is limited by some
contraindications, such as severe chronic obstructive pul-
monary disease, obesity, recent pneumothorax, and recent
pulmonary surgery [12]. Furthermore, the diaphragm and
inner organs are maintained in an intermediate position
between inspiration and expiration, which might some-
times limit access to high located lesions in the liver or
kidney.
A recent pilot study has suggested that HFJV could be
used for the tumor ablation [13]. This study described the
use of HFJV in nine patients. This small number of cases
did not demonstrate absence of organ movements during
this method of ventilation and did not illustrate risk or
pitfalls of this technique in this particular indication. Thus,
our study was designed to document the use of HFJV in a
larger subset of patients treated by tumor ablation, to
measure organ movements during HFJV, and to illustrate
benefit and limits of this technique.
Materials and Methods
This prospective, single-center study was conducted in a
university hospital and was approved with a waiver of
informed consent by the institutional review board of the
same hospital.
Study Design
Patients selected for local ablation after tumor board
meeting decision and after preoperative consultation with
interventional radiologists between May and December
2011 were included in intention to treat before the preop-
erative anesthesiologic visit. Inclusion criteria for the study
were age older than 18 years, informed consent of the
study obtained, and lesion accessible to percutaneous
treatment.
A total of 51 patients were identified (Table 1). No
patients were excluded based on our criteria; thus, the final
study population included 51 patients [14 women and 37
men; mean age 66 (range 37–80) years].
A total of 66 lesions were identified. Fifty-six lesions
were in the liver (30 hepatocellular carcinomas, 1 intra-
hepatic cholangiocarcinoma, 25 liver metastases), 5 in the
kidneys (4 renal cell carcinomas, one oncocytoma) and in
the lungs (2 epidermoid carcinomas, 3 lung metastases).
Lesions were solitary in 37 patients (73 %) and multiple in
14 (27 %); there were 2 lesions in 13 patients, and 3 lesions
in 1 patient.
Anesthesia Protocol
All patients had a preanesthesia visit and were classified
according to the physical status classification system of the
American Society of Anesthesiologists (ASA). Informed
consent for anesthesia was obtained. During this visit, all
contraindications for HFJV were specifically searched and
recorded when present. HFJV was contraindicated in case
of severe COPD (VEMS \1,500 ml/s), recent pneumo-
thorax or recent thoracic surgery because of the risk of
baro-traumatism, or severe obesity because of the risk of
hypercapnia [8].
After induction, anesthesia was maintained by a total
intravenous technique with propofol (0.15–0.2 mg/kg/min)
and remifentanil (0.2–0.3 lg/kg/min). Orotracheal intuba-
tion was performed under curare (vecuronium 0.1 mg/kg)
and conventional mechanical ventilation initiated. Just
before imaging, the anesthesia circuit was disconnected, a
dedicated 2-mm diameter jet catheter (Acutronic Medical
System AG, Hirzel, Switzerland) was slipped into the
endotracheal tube (Figs. 1, 2) and automatic HFJV was
initiated at a frequency of 150–250/min and a driving
pressure of 1–2 bar using the Monsoon jet ventilator
(Acutronic Medical System AG). Standard monitoring
consisted of blood pressure, ECG, peripheral O2 saturation,
ETCO2 during conventional mechanical ventilation and
bispectral index BIS (Philips Intellivue MP50, Switzer-
land). Specific monitoring during HFJV consisted of
transcutaneous CO2 (PTO2/PTCO2 Tosca TCM 4
,
Radiometer GMBH, Switzerland), alarm pressure cutoff of
the jet ventilator, as well as clinical monitoring of chest
movements and expiratory drive. At the end of the percu-
taneous thermal ablation, the HFJV catheter was removed,
conventional ventilation was resumed via the anesthetic
circuit and patient was awakened and extubated.
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As HFJV carries a higher risk of hypercapnia motivating
a switch to conventional high-pressure ventilation [12],
mean capnea was monitored as well as any anesthesia-
related complication. Duration of anesthesia was
registered.
Imaging Protocol
An interventional suite dedicated to percutaneous proce-
dures including a 128-multidetector CT (Phillips Ingenuity,
Best, The Netherlands), an US unit (IU22 Phillips
Healthcare, Best, The Netherlands) and the PercuNAV
image fusion and navigation system (PercuNAV, Best, The
Netherlands) were used.
CT was used in 11 patients as a guiding method for
needle placement in 6 thoracic tumors and in 7 liver tumors
invisible or poorly delineated under ultrasound. Acquisi-
tion were obtained on the targeted organ after injection of
iodinated nonionic contrast agent in all patients (300 mg of
iodine per ml) at a flow rate of 3 ml/sec (volume in mil-
liliters = body weight ? 30 ml) either at the arterial
(20–25 s) and venous phase (60–70 s) for abdominal
organs or at the venous phase (60–70 s) for thoracic pro-
cedure. After having chosen the reference plan for needle
placement, repeated acquisitions at this level were obtained
with a slab of 4 slices of 3.75-mm thickness (120 kV,
300 mA, table speed of 55 mm per rotation [0.7 s], pitch of
1.375). Dose length product was registered for each pro-
cedure (mGy/cm).
For organ movement measurement, a precise landmark
in the targeted organ, such as a vascular calcification, a
vascular, or a biliary bifurcation, was chosen on a central
image of the 4 slices acquisition. This landmark was
chosen to be distant of the needle tract or tumor to avoid
displacement due to needle positioning. Spatial coordi-
nates of this landmark were registered on 8 consecutive
slabs in x-, y-, and z-axis. For z-axis monitoring, our
measurement accuracy was limited to slice thickness or
multiple of it (3.75, 7.5 mm, and so on). Therefore, the
lower limit of movement measurement in the z direction is
3.75 mm.
For liver and kidney tumors, we used ultrasound
guidance using a 3.5-Mhz, curved, array probe, and we
used harmonic imaging at operator’s discretion. When
lesions were not visible under US and transiently identi-
fied after injection of contrast medium on CT, we used
the PercuNAV navigation system. This system allowed
real time fusion of preacquired CT images and US
pending cutaneous and internal anatomic landmarks
coregistration [14].
Procedure
Once the target lesion was identified either with US or CT,
the maximal diameter of the lesion as well as the distance
of the lesion to the skin entry point of the ablation probe
was noted in the study database. The ablation probes were
then advanced to their final position under HFJV using
either CT or/and US guidance. When necessary, correction
of the needle position was performed. The final position of
the ablation applicators was confirmed by a spiral CT
acquisition before the ablation was initiated. For all
Table 1 Flowchart of patient
51 patients,
14 W mean age 66 y.o.
Inclusion during pre-operative 
anesthesiology visit
2 patients contraindicated 
for HFJV before the 
procedure
Severe COPD
3 patients had to switch 
from HFJV to 
conventional ventilation 
Lesion invisible under 
HFJV (liver n=2, 
lung=1)
5 patients cancelled for 
HFJV
No trained 
anesthesiologist
41 patients used HFJV
HFJV group
HFJV
High frequency
Outflow through 
the orotracheal 
tube
Air turbulences caused by the 
high velocity flow maintain 
correct oxygenation at the 
alveolar level
Endotracheal tube
Venturi effect
HFJVcatheter 
High pressure
Fig. 1 Schematic drawing showing HFJV mechanism and set-up in
the trachea and bronchi. Small pushes of gaz injected at high pressure
in the HFJV catheter are pushed one by each other from the trachea to
the bronchus to allow oxygenation. The endotracheal tube is left
opened to allow gaz outflow
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patients CT acquisition was done at the end of the proce-
dure to evaluate extent of ablation, for possible complica-
tion depiction (pneumothorax, bleeding) and, for 11 patient
who had a CT as guiding method for needle placement, to
measure organ movement during HFJV. Additional ther-
mal ablations were performed when needed. All images
acquisitions were performed under HFJV.
Ablation Protocols
For RFA, internally cooled radiofrequency probe (Cluster
needle E series, Covidien, Dublin, Ireland) or coaxial
radiofrequency ablation device (LeVeen CoAccessTM
Electrode System, Boston Scientific, Natick, MA) were
used. For MWA, microwave antennas (Accu 2i pMTA
Microsulis, Hampstead, United Kingdom) and for cryoab-
lation, cryoprobes (Galil Medical, Yokneam, Israel) were
used. Liver lesions were treated by RFA or MWA
depending on their location and size. Renal tumors were
treated by RFA when they were exophytic and of small
size, whereas larger lesions (superior to 3 cm in diameter)
or lesions positioned close to the renal hilum or ureter were
treated by cryoablation. All primary or secondary pul-
monary tumors were treated by RFA. Standard ablation
protocols recommended by companies were used. RFA
ablation cycle lasted 12 min using Covidien perfused
needles and was depending on impedance roll-off phe-
nomenon for Boston Scientific multiprong needles,
whereas MWA lasted 6 min at 180 W and cryoablation
lasted twice 20 min (each 20 min cycle includes freezing,
passive, and active thawing). Duration of the ablative
procedure was registered.
Complications during and after treatment were regis-
tered using the Society of Interventional Radiology clas-
sification [15].
Results
Anesthesia Protocol
Physical status of patients was II in 30 patients and III in
21 patients according to ASA score. HFJV was used in 41
out of 51 patients. Two patients had severe COPD grade 2
and could not be ventilated using this technique. In 3
patients, HFJV made lesion either inaccessible (n = 1,
pulmonary metastasis from melanoma) or invisible
(n = 2, small liver metastasis in segment 8). We had to
switch to conventional ventilation method and to use
apnea under high positive pressure ventilation to make
lesions accessible/visible under US guidance. In one
patient having lung metastases in the posterior part of the
lung, the lesion was obscured by atelectasia under HFJV,
which resolved under conventional positive pressure
ventilation. In five cases, HFJV was cancelled due to the
absence of anesthesiologist certified for this technique and
patients received conventional positive pressure ventila-
tion. When treatment procedure necessitated a different
position than decubitus, HFJV also could be used in
patients positioned in procubitus (n = 4) or in lateral
position (n = 6).
Fig. 2 A The HFJV cannula is a long straight single lumen tube of
2 mm in diameter (black arrow). B During the procedure, it is
inserted into the orotracheal tube, which is left open to allow gaz
expulsion. C During the procedure, the small cannula (curved arrow)
coming from the Mansoon ventilation machine (white arrow) is
inserted in the orotracheal cannula (white arrow), which is left open
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Mean duration of anesthesia from induction to awak-
ening was 2 h (range: 1 h and 4 min–2 h and 55 min), with
a mean procedure duration of 1 h and 17 min (range,
35 min–2 h and 15 min). Duration of anesthesia in patients
who received HFJV compared with conventional ventila-
tion was slightly longer, 2 h and 5 min versus 1 h and
43 min respectively. The mean PCO2 was 37 mmHg in the
series with no difference between HFJV and conventional
ventilation patients (respectively 37 ± 6.5, and
36 ± 3.7 mmhg). We had 10 patients with per anesthesia
complications (2 delayed awakening, 2 hypotension, 1
difficult intubation, 1 extubation during procedure, 4
spontaneously resolutive cardiac arrhythmias) and one
severe postanesthesia complication consisting in a brachial
plexus paralysis due to arm mal positioning during the
procedure.
Ablative Procedures
RFA was used in 41 patients, MWA in 7 and cryoablation
in 3 patients. The mean size of the treated lesion was
1.8 ± 0.87 cm (range, 0.7–4 cm) and the skin to tumor
distance was 10 ± 3.1 cm (range, 4–16.2 cm). For small
hardly visible lesions under US, PercuNAV was used in 5
patients bearing 9 lesions (5 liver metastasis, 3 hepatocel-
lular carcinoma). These lesions were smaller than the
overall population (mean 1.2 ± 0.4 cm) and more deeply
located for ablation (mean skin to tumor distance:
11.7 ± 2.4 cm). Isolation from adjacent organs using
hydrodissection was used in 3 patients (colon, n = 2 and
stomach, n = 1). Percutaneous balloon occlusion of
hepatic veins was used in 2 patients [16]. One patient had a
right portal vein embolization during the same procedure.
Three patients necessitated repeated ablation after control
CT performed at the end of the procedure due to insuffi-
cient safety margin around the ablated lesion (two liver
metastases and one renal cell carcinoma). During and in the
30 days after the procedure, 18 of 51 patients experienced
complications according to SIR classification (Type A
n = 10, Type B n = 2, Type C n = 1, Type D n = 4,
Type E n = 1; Table 2). None of these complications
could be attributed to the ventilation method. Mean DLP
for the procedure was 1,177.5 mGy/cm with no difference
between patients under HFJV (mean 1,192.36 mGy/cm) or
conventional ventilation (1,116.57 mGy/cm).
Organ Movement During HFJV
Organ movement was measured in 11 patients (9 liver, 2
lung) using 8 repeated slabs of 4 slices of 3.75 mm in slice
thickness during needle positioning. During HFJV, the
mean movement of target is 0.3 ± 0.12, 0.3 ± 0.13, and
under 3.75 mm in x, y, and z directions respectively
(mean ± SD). Range of movement of targets is 0–1.06,
0.1–1.14, and \3.75 mm in x-, y-, and z-axis respectively
(Fig. 3).
Discussion
Our study demonstrated that HFJV is a useful anesthetic
ventilation method during percutaneous ablation proce-
dures. In our study group, this method was perfectly
applicable for different ablation methods in various organs
including liver, kidney, and lung. HFJV can be used as
demonstrated in our study even if the patient is positioned
in procubitus or lateral decubitus. HFJV could be used for
long procedures, such as combination of portal vein
embolization and RFA lasting 2 h. In our series, pending
strict selection criteria, no patient experienced hypercapnia
during anesthesia, and HFJV had never been stopped
because of ventilation difficulties.
Our study demonstrated than organ movement in x- and
y-axis was extremely limited (below 1 mm) in x- and
y-axis. Because slice thickness was 3.75 mm, we could
only measure target movement to be below 3.75 mm.
However, everyone will admit that this always less than the
standard liver vertical movement observed during breath-
ing or ventilation. Using conventional ventilation during
general anesthesia, conventional ventilator settings are
usually adjusted to deliver between 6 and 10 cc/kg of tidal
volume. A tidal volume of 600–800 cc is always associated
with movements of lungs, chest wall, and abdominal
organs [7]. During normal breathing, which uses similar
tidal volumes, organ motion was studied for purpose of
lung and abdominal radiotherapy. Movement amplitude in
Table 2 Complications related to the procedure according to SIR
classification [21]
A
Pneumothorax not drained n = 4
Perihepatic hematoma asymptomatic n = 5
Moderate fever at 48 h n = 1
Parietal hematoma n = 1
B
Acute pain during 72 h n = 1
C
Chronic abdominal pain lasting one month n = 1
D
Colic perforation during needle placement n = 1
Sepsis at day 2 n = 1
Hemobilia during ablation embolized n = 1
Delayed cholangitis at 1 month n = 1
E
Brachial plexus lesion during anesthesia n = 1
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the vertical direction has been described to be between 1
and 2 cm [17]. To our knowledge, our study is the first in
the literature to evaluate organ movement during HFJV in
human. HFJV has already demonstrated some clinical
benefits in non randomized trial for atrial fibrillation
ablation with shorter procedure duration [18] and for
extracorporeal shock wave lithotripsy with lower number
of shocks and less energy [19]. In a pilot retrospective
study, Abderhalden et al. [13] found that HFJV reduced the
dose-length product delivered to the patient compared with
conventional ventilation in a series of nine patients
receiving liver or kidney ablation during HFJV. We did not
observe this difference in our studies.
This method seems perfectly adapted for more advanced
guiding techniques, such as real-time fusion imaging. In
this technique, CT images are fused in real time with US
acquisition allowing for superposition on US images of
tumors only visible during CT acquisition after contrast
media injection [14]. Using this method, we were able to
treat deeply located tumors invisible under US with an
excellent precision using PercuNAV. HFJV also opens the
gate for more advanced technique, such as robotic place-
ment of needles, or precise treatment planning in large
tumors where multiple overlapping ablations and/or mul-
tiple applicators are needed. One indication of HFJV is
high-intensity, ultrasound ablation method to improve the
5 % rate of major complications in liver tumor ablation and
8 % in pancreatic tumor ablation [20]. Jung et al. [20]
emphasized the necessity of precise targeting of the treated
area and the risk of adjacent organ complication (myo-
cardium, spine, duodenum). Immobility of the target lesion
might help to reduce this complication rate.
HFJV has some limitations. It has its own contraindi-
cations as recommended by Bourgain et al. [8], such as
COPD, recent pneumothorax, or severe obesity. These
contraindications are not absolute and the risk of the
anesthesia could be weighted by the potential benefit of the
procedure. HFJV is not widely used therefore not all
anesthesiologist are confident in using it. In our study 10 %
of cases could not be treated using HFJV because anes-
thesiologist team was not trained. More extensive use of
this method should avoid these problems in the future.
Another potential advantage of this technique lies in the
lower peak airway pressures used. This could be an
advantage in the case of lung tumor ablation as we can
expect that air-leaks though the pleura should be limited in
comparison with ablation performed under conventional
positive airway pressure, which use much higher pressure.
In three patients (6 %), HFJV made tumor ablation
impossible because it made lesion either inaccessible or
invisible. Indeed patients under HFJV had the diaphragm in
Fig. 3 Repeated CT acquisitions at the same level during needle
placement (white arrow head) in a segment 8 liver metastasis. A A
punctiform calcification is identified in segment 7 (bold white arrow).
B, C Spatial coordinates in x- and y-directions of this calcification
shows no significant movement during HFJV
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intermediate position because intra-alveolar and intrapul-
monary pressure are intermediate, which may make some
lesions (e.g. in the dome of the liver) difficult to access or
make lung lesion invisible due to atelectasis. For these
three patients, HFJV could be switched to conventional
ventilation with apneas under positive pressure ventilation,
which made the lesions visible, and ablations could be
performed.
In conclusion, we found the use of HFJV very useful for
the ablation of tumors in the liver, kidneys, and lungs. Our
study demonstrated barely any organ movement during
ventilation. Furthermore, the risk of complications related
to this technique seems limited pending a trained anesthetic
team. This ventilation technique opens the gate for more
sophisticated development, such as robotic, and the use of
ablation techniques necessitating long ablation cycles with
external energy sources, such as high-intensity focused
ultrasound. In our study, we did not use CT fluoroscopy,
which also is a useful tool for difficult placement and might
have reduced procedure time.
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